If You’re Confused About the New FDA Action Regarding Kratom and 7OH, Watch This
The FDA is taking action to protect public health by initiating the process to schedule concentrated synthetic 7-hydroxymitragynine (7-OH) opioid products. The FDA made clear that natural kratom leaf is not the focus of this action. The focus is on the new wave of concentrated synthetic 7-OH opioid products that…